Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Drug Manufacturers
Aspen Pharmacare Holdings Ltd (JSE:APN) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue Growth Amidst Challenges
Aspen Pharmacare Holdings Ltd (JSE:APN) reports a 10% revenue increase and significant EBITDA growth despite geopolitical and market pressures. Sep 14, 2024
Drug Manufacturers
Aspen Pharmacare Holdings Ltd (JSE:APN) (Q2 2024) Earnings Call Transcript Highlights: Strong Revenue Growth Amid Operational Challenges
Aspen Pharmacare Holdings Ltd (JSE:APN) reports a 10% year-over-year revenue increase and robust cash flow performance despite facing significant market and operational hurdles. Sep 14, 2024
Drug Manufacturers
Adcock Ingram Holdings Ltd (JSE:AIP) (Q2 2024) Earnings Call Transcript Highlights: Steady Revenue Growth Amidst Operational Challenges
Adcock Ingram Holdings Ltd (JSE:AIP) reports a 1.4% revenue increase and a mixed performance across divisions in its Q2 2024 earnings call. Sep 14, 2024